Clinical Director
CurrentAt PharmaValue Partners, I lead initiatives focused on clinical trial optimization and new product commercialization. My role involves ensuring that patient insights and advocacy group feedback are embedded into trial design, streamlining site onboarding, and optimizing patient recruitment strategies. I collaborate with cross-functional teams to align R&D and commercial strategies, ensuring that new therapies are developed with both clinical efficacy and market success in mind.In addition to trial optimization, I conduct horizon scanning and leverage epidemiological data to forecast future market needs and identify emerging opportunities. This ensures that our clients stay ahead in a competitive landscape, especially in areas like oncology and cell therapies. I have also led research in resource-limited settings (RLS), working with PAGs to incorporate diverse patient perspectives into clinical development.Key Achievements:-Led clinical trial optimization projects to reduce site onboarding times and improve patient recruitment rates- Conducted horizon scanning and epi data forecasting initiatives to support new product launches and strategic market planning.-Aligned patient-centric R&D with commercial strategy, ensuring a smoother transition from clinical development to successful product launches.-Led research projects in resource-limited settings (RLS), ensuring underrepresented patient populations were included in clinical trial designs.-Developed frameworks that integrated PAG feedback into both trial designs and market entry strategies, improving product adoption by healthcare providers.